Picture of LifeStance Health logo

LFST — LifeStance Health News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Lifestance Health Group Inc expected to post a loss of 9 cents a share - Earnings Preview

* Lifestance Health Group Inc  LFST.OQ   LFST.O  is expected
to show a rise in quarterly revenue when it reports  results on
February 28 for the period ending December 31 2023
    * The Scottsdale Arizona-based  company is expected to
report a
14.6% increase in revenue to $263.003 million from $229.4
million a year ago, according to the mean estimate from 6
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Lifestance Health Group
Inc is
for a loss of 9 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lifestance
Health
Group Inc is $8.00​, above​ its last closing price of $6.23. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.08       -0.08      -0.17     Missed  -112.5
 Jun. 30 2023  -0.09       -0.09      -0.13     Missed  -50
 Mar. 31 2023  -0.11       -0.11      -0.09     Beat    16.3​
 Dec. 31 2022  -0.13       -0.13      -0.13     Met     -1.3
 ​​Sep.        -0.13       -0.14      -0.11     Beat    20.5
 30 2022                                                
 Jun. 30 2022  -0.15       -0.14      -0.19     Missed  -35.7​
 Mar. 31 2022  -0.20       -0.17      -0.18     Missed  -4.7
 Dec. 31 2021  -0.20       -0.21      -0.33     Missed  -55.9
 This summary was machine generated February 26 at 13:40 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on LifeStance Health

See all news